Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-159-0 | CAS number: 68015-93-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 October 2015 - 13 April 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Octadec-2-enylsuccinic acid
- EC Number:
- 268-159-0
- EC Name:
- Octadec-2-enylsuccinic acid
- Cas Number:
- 68015-93-0
- Molecular formula:
- C22H40O4
- IUPAC Name:
- 2-octadec-2-en-1-ylsuccinic acid
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- Identification: EXP1505385
Label Lot No.: E00350-288
Batch No: E00974-38D&F
Re-test Date: 22 June 2018*
Physical Description: Pale amber waxy solid
Purity: 100 %
Storage Conditions: Ambient temperature/ Dark
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- Crl:CD (SD) (
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Twelve female Sprague-Dawley Crl:CD (SD) (nulliparous and non-pregnant) rats were supplied by Charles River, Margate, UK and arrived at the Test Facility on 27 Oct2015. Nine rats were used on this study and the remaining 3 animals (scheduled for treatment in Group 4) were not used and returned to stock after completion of the study. Animals were approximately 7 to 8 week old on despatch and weighed between 176 and 200 g. On the day of dosing animals were approximately 8 to 11 weeks old and weighed between 180 and 229 g. All animals weighed within +/- 20% of the mean body weight of the previously dosed groups.
The animals were allowed to acclimatise to the Test Facility rodent toxicology accommodation for a period of at least 8 days before dosing.
Animals were housed in groups of 3 in appropriately sized solid-bottomed polycarbonate cages with stainless steel mesh tops. Wood shavings were used as bedding.
Husbandry practices and environmental enrichment were in accordance with Test Facility SOPs and the protocol. SDS Rat and Mouse (modified) No. 1 Diet SQC Expanded was available ad libitum. Food was withdrawn overnight before dosing, and returned as soon as practicable after administration of the test item. Water from the public supply was available ad libitum.
Certificates of analysis for significant contaminants in diet, water, bedding and environmental enrichment materials are retained at the Test Facility. There were no contaminants present in significant quantities that would have interfered with the objectives of the study.
The environmental conditions were continually monitored and recorded every 15 min. Target ranges were 19¿C to 23°C for temperature and 40% to 70% for relative humidity. From animal arrival, the temperature was between approximately 19¿C and 23¿C and the relative humidity was approximately 31% to 74%. On occasions where the target environmental conditions were not mentioned the change was transient and did not trigger the internal alarm and notification procedure at the Test Facility. The health of the animals was unaffected in any occasion, and these events were considered not to have had an impact on the outcome or integrity of the study.
A 12 h light/dark cycle was in operation (light hours 0700-1900 h) with a minimum of 10 air changes per hour.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- The animals received a single oral dose via a gavage tube after being deprived of food overnight. The doses were calculated on the basis of each animal’s body weight on the day of dosing.
- Doses:
- Dose level of 300 mg/kg and 2000 mg/kg were used
- No. of animals per sex per dose:
- 3 animals were tested at 300 mg/kg
6 animals were tested at 2000 mg/kg - Control animals:
- no
- Details on study design:
- A dose of 300 mg/kg was selected as a suitable starting dose level for administration to Group 1 animals. There were no adverse signs in these animals so 2000 mg/kg was chosen as dosage level for Group 2, and as there were no unscheduled deaths, the third group of rats was treated at the same dose level to complete the study.
All animals were for checked for mortality early each morning and as late as possible each day for viability. All animals were examined for clinical signs to treatment for up to 5 hours post dosing on the day of dosing and once daily thereafter, until Day 15. The body weight of each individual animal was recorded before dosing on Day 1 and on Days 8 and 15.
Animals were euthanised on Day 15 by exposure to a rising concentration of carbon dioxide followed by exsanguination. Gross necropsy was performed on all animals. The necropsy consisted of an examination of the cranial, thoracic and abdominal organs and tissues in situ. - Statistics:
- No formal statistical analysis was conducted.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no unscheduled deaths.
- Clinical signs:
- other: There were no adverse signs noted at 300 mg/kg. After treatment at 2000 mg/kg adverse clinical signs were noted from 15 minutes after dosing up to 3 days after dosing (Day 4). The majority of adverse signs were recorded 30 minutes to 2 hours after dosin
- Gross pathology:
- There were no macroscopic abnormalities in any animal.
- Other findings:
- Not Applicable
Any other information on results incl. tables
See attached background document
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The median lethal dose level (LD50) of Substance was considered to be > 2000 mg/kg.
- Executive summary:
The objective of this study was to assess the adverse effects which can follow within a short period of time after a single oral (gavage) administration of the test item, Substnace to rats.
The test item was administered to 3 groups of female Sprague- Dawley rats. The study design was as follows:
Text Table1
Experimental DesignGroup
NumbersNumber of Animals
Dose Level
(mg/kg)Dose Volume
(mL/kg)Dose
Concentration (mg/mL)1
3
300
10
30
2
3
2000
10
200
3
3
2000
10
200
The following parameters and end points were evaluated in this study: clinical signs, body weights, body weight changes, and on Day 15, gross necropsy findings.
There were no unscheduled deaths. There were no adverse signs noted at 300 mg/kg. After treatment at 2000 mg/kg adverse clinical signs were noted from 15 minutes after dosing up to 3 days after dosing (Day 4). The majority of adverse signs were recorded 30 minutes to 2 hours after dosing, and included decreased activity, eyes partly closed, piloerection (fur erect), a hunched appearance and abnormal gait. There were wet muciod feaces between 3-4 hours after dosing. The animals gradually recovered and 3 days after dosing only one animal still had a hunched appearance. There were no adverse signs from Day 5. Slight body weight loss of approximately 2% in 3 of the animals that received 2000 mg/kg, when body weights recorded on Day 8 were compared with those on Day 15. The body weight gains of animals at 300 or 2000 mg/kg were generally considered to be acceptable for rats of this age and strain. There were no macroscopic abnormalities in any animal.
Under the conditions of the study the median lethal dose level (LD50) of test Substance in Sprague-Dawley rats was considered to exceed 2000 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.